tr.euronews.com
Global Governments Face Urgent Call to Action on Non-Communicable Diseases
A new report reveals that governments drastically underfund non-communicable disease (NCD) treatment, creating disparities in access to essential medicines, particularly in low- and middle-income countries, prompting a global call for increased investment and strategic purchasing.
- What is the most significant funding gap revealed by the report, and what are its immediate implications?
- The report highlights a massive underfunding of NCDs, with low- and middle-income countries spending only 0.26%–0.46% of their gross national income (GNI) on NCDs. This leads to limited access and high out-of-pocket costs for patients, creating a dual crisis of affordability and availability.
- How do disparities in medicine pricing contribute to the NCD crisis, and what are the potential solutions?
- Medicine prices vary dramatically across countries, with low- and middle-income countries often paying the highest prices for the same drugs. The report suggests that implementing "smart purchasing policies," such as pooled procurement, could reduce costs by 20%–50%, making treatment significantly more affordable.
- What are the long-term implications if governments fail to address the current funding gaps and pricing disparities in NCD treatment?
- Failure to act will exacerbate existing health inequalities and hinder progress towards universal health coverage. The report recommends increasing investment in primary healthcare to 1.1%–1.7% of GNI, with 20%–54% allocated to medicines, and implementing strategic purchasing strategies to ensure equitable access to essential NCDs medications.
Cognitive Concepts
Framing Bias
The article presents a balanced view of the issue, highlighting both the problem of inadequate funding for NCDs and potential solutions. While it emphasizes the urgency of the situation and the need for increased government action, it also presents data and expert opinions from various sources.
Language Bias
The language used is largely neutral and objective. The article avoids emotionally charged language and presents facts and figures from the report. Terms like "fahiş fiyatlar" (exorbitant prices) are translated and the context makes the meaning clear.
Bias by Omission
The article could benefit from including information on specific initiatives or programs that are already underway to address NCD funding and access to medication. It also doesn't explore potential barriers beyond funding, such as healthcare infrastructure or workforce limitations.
Sustainable Development Goals
The article directly addresses the UN SDG 3, Good Health and Well-being, by focusing on the global rise of non-communicable diseases (NCDs) and mental health issues. It highlights the insufficient funding for NCD treatment, unequal access to medication, and the need for increased government investment. The proposed solutions, such as pooled procurement and price transparency, aim to improve access to essential medicines and healthcare services, thereby directly contributing to better health outcomes. The article emphasizes the disproportionate impact on low- and middle-income countries, further highlighting the inequality aspect of SDG 3.